Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthranilic acid-based compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same

Anthranilic acid-based compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same

US Patent 12357626 · Granted Jul 15, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases 2022
Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases 2022
Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases 2022
Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases 2022
Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon c2021
Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon c2021
Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon c2021
Ester compound and PIN1 inhibitor, inflammatory disease therapeutic, and colon c2021
Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity2021
Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity2021
Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity2021
Therapeutic agent for fatty liver diseases and therapeutic agent for adiposity2021